FABRIS, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 7.093
EU - Europa 3.723
AS - Asia 2.673
SA - Sud America 65
OC - Oceania 35
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 13.620
Nazione #
US - Stati Uniti d'America 7.034
IT - Italia 1.259
SG - Singapore 817
CN - Cina 764
SE - Svezia 700
HK - Hong Kong 693
DE - Germania 324
RU - Federazione Russa 244
BG - Bulgaria 200
IE - Irlanda 169
UA - Ucraina 151
PL - Polonia 121
GB - Regno Unito 120
FI - Finlandia 110
TR - Turchia 103
IN - India 79
CH - Svizzera 71
JP - Giappone 69
FR - Francia 54
NL - Olanda 54
BR - Brasile 38
CA - Canada 35
ES - Italia 32
VN - Vietnam 30
AT - Austria 28
AU - Australia 27
IR - Iran 25
KR - Corea 24
BE - Belgio 22
MX - Messico 20
SN - Senegal 17
RO - Romania 15
DK - Danimarca 14
KZ - Kazakistan 14
ID - Indonesia 13
TW - Taiwan 11
AR - Argentina 10
CZ - Repubblica Ceca 10
EU - Europa 9
GR - Grecia 9
NZ - Nuova Zelanda 8
CO - Colombia 6
MY - Malesia 6
PE - Perù 6
TH - Thailandia 6
PK - Pakistan 5
SV - El Salvador 4
EC - Ecuador 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
EG - Egitto 2
PH - Filippine 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.620
Città #
Fairfield 909
Singapore 695
Hong Kong 674
Chandler 668
Woodbridge 627
Ashburn 581
Wilmington 461
Seattle 432
Houston 431
Ann Arbor 408
Cambridge 291
Princeton 259
Boardman 256
Trieste 246
Beijing 221
Jacksonville 220
Sofia 200
Dublin 164
Columbus 155
Moscow 144
Warsaw 112
Santa Clara 110
Milan 77
Izmir 71
Helsinki 65
Rome 64
Dearborn 63
San Diego 59
Venezia 50
Bern 48
Grafing 38
Rostock 35
Redwood City 34
Shanghai 33
Nuremberg 30
Washington 29
Turin 27
Dong Ket 26
Tokyo 24
Jinan 22
Los Angeles 22
Guangzhou 21
Des Moines 20
Mumbai 20
Naples 20
Toronto 20
Brussels 19
Bremen 18
London 18
Nanjing 18
Dakar 17
Monfalcone 16
Munich 16
Redmond 16
Vienna 16
Brescia 15
Pune 15
Wuhan 15
Falls Church 14
Frankfurt am Main 14
Lappeenranta 14
Bari 13
Dallas 13
Falkirk 13
Florence 13
Madrid 13
Padova 13
Bologna 12
Seoul 12
Palermo 11
Zhengzhou 11
Andover 10
Chicago 10
Hefei 10
Mykolayiv 10
Portici 10
Shenyang 10
São Paulo 10
Valenzano 10
Aarhus 9
Bergamo 9
Kocaeli 9
Kunming 9
Norwalk 9
San Jose 9
Udine 9
Ancona 8
Cagliari 8
Catania 8
New York 8
Shenzhen 8
Sydney 8
Timisoara 8
Amsterdam 7
Asheville 7
Auckland 7
Barcelona 7
Dongguan 7
Perth 7
San Mateo 7
Totale 9.795
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 403
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 310
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 298
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 261
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 219
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 215
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 212
Coronary covered stents 211
Treatment of Functional Mitral Regurgitation in Heart Failure 207
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 196
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 188
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 180
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 179
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 177
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 172
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 169
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 165
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 165
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 164
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 161
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 159
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 156
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 155
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 155
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 150
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 150
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 143
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 142
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 142
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 142
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 141
null 135
Impact of patient delay in a modern real world STEMI network 134
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 133
null 131
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 130
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 128
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 128
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 125
The evolution of cardiology: Changes, future challenges and opportunities 119
Nonatherosclerotic Coronary Artery Narrowing 118
If heart failure or cardiac arrest complicate pregnancy and delivery 116
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 116
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 114
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 113
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 113
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 113
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 112
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 112
null 108
Direct cellular reprogramming: the hopes and the hurdles 108
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 108
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 102
Clinical Spectrum of PRKAG2 Syndrome 100
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 99
Insufficienza tricuspidale e indicazioni al trattamento 96
Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review 95
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 95
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 95
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 94
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 93
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 92
Natural history of spontaneous coronary dissections 90
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 87
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 82
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry 80
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 75
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 74
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 74
Thoracic pain: Clinical features 72
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 70
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 69
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 69
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 69
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 68
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention 68
Effect of prehospital treatment in STEMI patients undergoing primary PCI 68
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 66
Near-infrared spectroscopy-intravascular ultrasound: Scientific basis and clinical applications 66
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 65
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 64
Pathogenesis 64
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 63
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 62
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 62
Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation 59
Rimodellamento inverso nei pazienti con disfunzione ventricolare sinistra: predittori di miglioramento e revisione della letteratura 59
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study 58
Intravascular Imaging Guidance of Left Main PCI: Nice to Have or Must Have? 58
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 58
Variation in treatment strategy for NSTEMI: A complex phenomenon 58
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial 57
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 57
Angiography and electrocardiography (ECG) for the assessment of coronary microvascular obstruction 56
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial 56
Influence of multimodality coronary imaging on revascularization strategy 54
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial” 54
Antithrombotic therapy in heart failure and sinus rhythm: the ongoing search for a better match of patients to therapy 53
Appropriateness and surroundings: "Doing more does not mean doing better". Choosing wisely, an unfulfilled commitment? 52
Entrapment of dissection flap and intimal tissue cleavage during rotational atherectomy 52
Totale 11.830
Categoria #
all - tutte 51.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.175 0 0 0 0 0 0 179 173 203 386 139 95
2020/20212.358 95 123 135 532 303 224 228 121 101 194 109 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20242.039 106 95 76 119 147 231 292 390 29 112 222 220
2024/20252.791 189 428 535 429 456 674 80 0 0 0 0 0
Totale 14.346